- Home
- NMRA vs BWFG Comparison
NMRA vs BWFG Comparison
Compare NMRA & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- BWFG
- Stock Information
- Founded
- NMRA 2019
- BWFG 2002
- Country
- NMRA United States
- BWFG United States
- Employees
- NMRA N/A
- BWFG N/A
- Industry
- NMRA
- BWFG Major Banks
- Sector
- NMRA
- BWFG Finance
- Exchange
- NMRA Nasdaq
- BWFG Nasdaq
- Market Cap
- NMRA 287.6M
- BWFG 256.7M
- IPO Year
- NMRA 2023
- BWFG N/A
- Fundamental
- Price
- NMRA $1.80
- BWFG $30.61
- Analyst Decision
- NMRA Strong Buy
- BWFG Buy
- Analyst Count
- NMRA 6
- BWFG 1
- Target Price
- NMRA $20.67
- BWFG $40.00
- AVG Volume (30 Days)
- NMRA 2.0M
- BWFG 13.3K
- Earning Date
- NMRA 03-06-2025
- BWFG 01-22-2025
- Dividend Yield
- NMRA N/A
- BWFG 2.61%
- EPS Growth
- NMRA N/A
- BWFG N/A
- EPS
- NMRA N/A
- BWFG 1.17
- Revenue
- NMRA N/A
- BWFG $64,379,999.00
- Revenue This Year
- NMRA N/A
- BWFG N/A
- Revenue Next Year
- NMRA N/A
- BWFG $12.49
- P/E Ratio
- NMRA N/A
- BWFG $26.16
- Revenue Growth
- NMRA N/A
- BWFG N/A
- 52 Week Low
- NMRA $1.60
- BWFG $22.47
- 52 Week High
- NMRA $21.00
- BWFG $35.25
- Technical
- Relative Strength Index (RSI)
- NMRA 27.76
- BWFG 45.46
- Support Level
- NMRA $1.61
- BWFG $31.25
- Resistance Level
- NMRA $1.80
- BWFG $31.66
- Average True Range (ATR)
- NMRA 0.11
- BWFG 0.82
- MACD
- NMRA 0.23
- BWFG -0.06
- Stochastic Oscillator
- NMRA 51.28
- BWFG 25.52
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses, and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.